Clinical trials
Completed Phase 2 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,556 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 7 |
| 2002 | 13 |
| 2003 | 25 |
| 2004 | 28 |
| 2005 | 43 |
| 2006 | 49 |
| 2007 | 59 |
| 2008 | 84 |
| 2009 | 85 |
| 2010 | 78 |
| 2011 | 88 |
| 2012 | 102 |
| 2013 | 66 |
| 2014 | 65 |
| 2015 | 90 |
| 2016 | 83 |
| 2017 | 76 |
| 2018 | 70 |
| 2019 | 89 |
| 2020 | 77 |
| 2021 | 110 |
| 2022 | 75 |
| 2023 | 47 |
| 2024 | 33 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,556 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 79 |
| GlaxoSmithKline | 73 |
| Hoffmann-La Roche | 71 |
| AstraZeneca | 63 |
| Novartis Pharmaceuticals | 48 |
| Bayer | 47 |
| Bristol-Myers Squibb | 46 |
| Eli Lilly and Company | 46 |
| Janssen Research & Development, LLC | 46 |
| Sanofi | 37 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 106 |
| Asthma | 65 |
| Colitis, Ulcerative | 53 |
| Carcinoma, Non-Small-Cell Lung | 52 |
| Diabetes Mellitus, Type 2 | 51 |
| Breast Neoplasms | 42 |
| Pulmonary Disease, Chronic Obstructive | 40 |
| Dermatitis, Atopic | 35 |
| Lupus Erythematosus, Systemic | 33 |
| Heart Failure | 32 |
Trials
Showing 1 to 25 of 1,556. Each trial links to its page on Pharma Observatory.
1,456 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.